A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma.
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAnti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAddition of anti-leukotriene agents to inhaled corticosteroids for chronic asthmaMolecular cloning and expression of human leukotriene-C4 synthaseAn update on PAFAsthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.Effects of antileukotrienes in the treatment of asthma.Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma.Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma.Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroidsPranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma.Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosisLeukotrienes as therapeutic target in asthma.Clinical studies with agents active on the 5-lipoxygenase pathway.Eicosanoids and asthma.Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.TH2-type cytokines in asthma.Human late asthmatic reactions.The effects of a novel sulphidopeptide leukotriene antagonist, BAY x7195, against elicited bronchoconstriction in the anaesthetized guinea-pig.Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.Clinical effects of pranlukast, an oral leukotriene receptor antagonist, in mild-to-moderate asthma: a 4 week randomized multicentre controlled trial.Inflammation, inflammatory mediators, and mediator antagonists in asthma.Inhibitory effect of inhalation of a thromboxane synthetase inhibitor on bronchoconstriction induced by aerosolized leukotriene C4 and thromboxane A2 analogue in anesthetized guinea pigs.Studies of the combination of Ro 24-5913, a peptidoleukotriene antagonist, and Ro 24-4736, a PAF antagonist, in guinea pig and rat models of lung inflammation.Leukotriene receptor antagonism and augmentation of beta-receptor-mediated events by LY171883.Stereoselective metabolism of the 5-lipoxygenase inhibitor A-78773.Leukotrienes as Mediators of Airway Obstruction
P2860
Q24197682-0A6BFB77-1A49-41B1-945F-04DDCE90DBEAQ24247433-F510C579-DABF-463E-ADC7-2B449A5B746BQ24247489-43EF0E9A-20C0-432B-80ED-3B660BBB3E0BQ24563556-C18EF6E3-D3AB-4280-AC31-98CB4C509316Q28609458-41CE0BAE-1BAB-4E5E-9207-A6493893CC5DQ33595339-754F7302-079A-49F3-B682-F5275071E48EQ33836725-A270C38D-E72A-46DA-B11E-CB8A93466EA4Q33976334-A4AAD16A-FEB4-4617-A272-054611B214C9Q33978718-9467DBDC-DE79-4F3B-A7F9-FAED32721800Q34424227-BAB3852E-E4ED-4BAD-B51E-8EF44D55AD52Q35563114-83E969BA-8A2E-4D91-94D7-4D6175368DBFQ35563656-B687AFCD-E910-4F1B-81D3-51239BB05D42Q37354132-FFD1BB96-0DDC-4BEE-B764-1FC28E731738Q40383957-E90208EC-8973-4101-9F29-67E307047621Q40551743-5C9BD6CE-BBDF-4696-933B-F1EBFD490FA7Q40572532-9C936F30-D088-4E01-97FD-D5EF2888636CQ40933985-1A12F19C-BBCC-46F2-8D61-1ED91227F04AQ41200649-F9908C54-A084-40B2-BA90-A81841456DEEQ41494401-5F3D96C3-9CE5-4443-8A53-FCF66EE753EEQ41984463-E5BB3196-1C97-4329-868E-646C33DDBFFDQ42126419-BAF48202-0622-4DB5-91AF-A370E5F1EA5EQ42544259-DF44F420-ECF3-4C4B-93AA-3AEBE4E08E15Q43551417-60172AB8-B2C1-499E-B64F-C98E7BF84F9DQ45071770-B44B66C2-75B5-4F30-95FD-1B2CB6D89ED1Q46248959-81C6F522-D154-4F05-958A-E652B8067C42Q46692047-A73C322C-C9E5-4E04-8D11-5410D56CBA80Q46899306-30556843-1F56-41E4-84CE-9F6F76F45BB4Q54191161-3F897D2A-86EB-408A-BB29-0B9C13EF01E1Q57240752-8DAD9B52-88D8-4116-9570-8ECE72161800
P2860
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
A specific LTD4/LTE4-receptor ...... nts with mild, chronic asthma.
@en
type
label
A specific LTD4/LTE4-receptor ...... nts with mild, chronic asthma.
@en
prefLabel
A specific LTD4/LTE4-receptor ...... nts with mild, chronic asthma.
@en
P2093
P2860
P356
P1476
A specific LTD4/LTE4-receptor ...... nts with mild, chronic asthma.
@en
P2093
Middleton E
Platts-Mills T
Sheffer AL
Tinkelman D
P2860
P304
P356
10.1164/AJRCCM/140.5.1336
P577
1989-11-01T00:00:00Z